| Market Cap | ₹1,47,936Cr |
| ROE | 25.33% |
| P/E Ratio(TTM) | 65.11 |
| EPS(TTM) | 67.13 |
| P/B Ratio | 17.51 |
| Dividend Yield | 0.14% |
| Industry P/E | 32.50 |
| Book Value | 249.65 |
| Debt to Equity | 0.33 |
| Face Value | 5 |
| Managing Director | NA |
| NSE Symbol | TORNTPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Ajanta Pharma | NA (0.00%) | 36.51 | ||
| Gland Pharma | NA (0.00%) | 34.91 | ||
| Sai Life Sciences | NA (0.00%) | 63.35 | ||
| Eris Lifesciences | NA (0.00%) | 40.12 |